Rapid Dose Therapeutics and McMaster University Initiate QuickStrip™ COVID-19 Vaccine Research With Immediate Impact
July 21, 2020 07:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, July 21, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active...
Rapid Dose Therapeutics Announces Delay in Annual Filings Under COVID-19 Duress
June 26, 2020 16:15 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that due to circumstances created by the COVID-19 pandemic, the...
Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process
June 19, 2020 07:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, June 19, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active...
RAPID DOSE THERAPEUTICS Signs agreement with Leede Jones Gable to provide Financial Advisory Services and Announces Change to its Board of Directors
May 29, 2020 08:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, May 29, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active...
RAPID DOSE THERAPEUTICS DONATES QUICKSTRIP™ VITAMIN B12 NUTRACEUTICAL PRODUCT TO COMMUNITY
April 02, 2020 08:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, April 02, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) in response to the COVID pandemic, recently made a donation to the...
RAPID DOSE THERAPEUTICS ANNOUNCES SHIPMENT OF QUICKSTRIP™ NUTRACEUTICAL PRODUCTS
March 31, 2020 08:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, March 31, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce that RDT has completed its first shipment of...
Rapid Dose Therapeutics Announces Investment Agreement With Institutional Investor
March 05, 2020 08:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, March 05, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) today announced that it has entered into an agreement for a drawdown...
Rapid Dose Therapeutics Announces Nutraceutical Reseller Agreement for Canada, United States and India
February 27, 2020 08:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce an Agreement with Perennial Brands, a DCM...
Rapid Dose Therapeutics Announces Issuance of CRA Cannabis Licence and Board and Management Changes
February 21, 2020 08:00 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce receipt of its Canada Revenue Agency (CRA)...
Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product
February 04, 2020 07:15 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) (“RDT” or the “Corporation”) is pleased to announce the company has...